Prevalence and impact of Rome IV versus Rome III irritable bowel syndrome in patients with inflammatory bowel disease.

Keeley M FairbrassChristian P SelingerDavid J GracieAlexander Charles Ford

Published in: Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society (2021)

Rome IV IBS-type symptoms are associated with increased psychological co-morbidity, lower quality of life scores, and higher rates of antidepressant or opioid use. This is a cohort potentially at risk of adverse clinical outcomes and should be a focus for future research.

Keyphrases

irritable bowel syndrome
patients with inflammatory bowel disease
major depressive disorder
risk factors
sleep quality
depressive symptoms
drug induced